Robert Lechleider, Chief Medical Officer, on June 25, 2026, sold 55,000 shares in Immunome (IMNM) for $1,091,662. Following the Form 4 filing with the SEC, Lechleider has control over a total of 15,805 common shares of the company, with 15,805 shares held directly.
SEC Filing: